Comparison
2q13 Microdeletion Syndrome C6012360 vs 14q32 Duplication Syndrome C4225449
Clinical comparison between 2q13 Microdeletion Syndrome and 14q32 Duplication Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
14q32 Duplication Syndrome C4225449
A rare chromosomal disorder where extra genetic material from chromosome 14 is present. It can affect development and cause intellectual disability, distinctive facial features, and other health issues. Management focuses on addressing symptoms with specialized care.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
14q32 Duplication Syndrome C4225449
0-0
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
14q32 Duplication Syndrome C4225449
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
14q32 Duplication Syndrome C4225449
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
14q32 Duplication Syndrome C4225449
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
14q32 Duplication Syndrome C4225449
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
14q32 Duplication Syndrome C4225449
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 14q32-duplication-syndrome-C4225449 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 14q32 Duplication Syndrome C4225449 | Discriminating power |
|---|---|---|---|
| Chromosomal change | A small segment of chromosome 2 at 2q13 is missing. | Extra genetic material from chromosome 14 at 14q32 is present. | High |
| Developmental features | Development and distinctive features may be affected; exact features are not established here. | Development, intellectual disability, and distinctive facial features may occur. | Moderate |
| Reported severity | Source severity is labeled severe, but individual course can vary. | Source severity is labeled moderate, without a fixed outcome. | Low |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
A confirmed 2q13 deletion explains the presentation.
The defining evidence is missing chromosome 2 material, interpreted by a genetics clinician.
High
Onset or recognized features appear at variable ages.
The supplied onset is variable rather than fixed at birth.
Moderate
Care needs appear substantial across several domains.
The source labels severity severe and supports symptom-based specialist care.
Low
Choose 14q32 Duplication Syndrome C4225449 when
Testing confirms extra 14q32 material.
Duplication of chromosome 14 material distinguishes it from a 2q13 deletion.
High
Concerns are recognized around birth.
The supplied onset is recorded as 0-0, suggesting congenital recognition.
Moderate
Intellectual disability or facial differences are prominent.
These are specifically mentioned for this condition, though not definitive in every person.
Moderate
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 14q32 Duplication Syndrome C4225449 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a 2q13 deletion. | May show a 14q32 duplication. | The result identifies a chromosomal imbalance; a clinician must correlate it with the person. |
| Karyotype | A small deletion may not be visible. | A small duplication may not be visible. | A normal karyotype does not exclude either condition. |
| Clinical genetics review | Integrates variable developmental and physical findings. | Integrates developmental, cognitive, and facial findings. | Neither pattern alone establishes the diagnosis without appropriate genetic evidence. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- A chronic, variable course is expected; no specific survival outcome is established.
- Factors
- Confirmed deletion, developmental needs, and associated health findings may influence support needs.
14q32 Duplication Syndrome C4225449
- Outcome
- A chronic course with potentially moderate impact is suggested; outcomes vary.
- Factors
- Confirmed duplication, cognitive needs, and other health issues may influence support needs.
Time frame: Often lifelong, with recognition from birth or at variable ages.
Individual prognosis requires clinician interpretation and cannot be fixed from these sparse data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Development may be affected to a variable degree. Development and intellectual disability may occur. Specific deficits and their frequency are not established by these sources. |
| Physical differences | Distinctive features may occur, without a fixed list here. Distinctive facial features and other health issues may occur. Organ-specific complications should not be assumed without evaluation. |
| Family implications | Relatives may need genetics counseling after confirmation. Relatives may likewise need counseling after confirmation. Inheritance and recurrence cannot be determined from the supplied data. |
Patient education highlights
- HighMeaning of the result
A chromosomal finding needs specialist interpretation and does not by itself predict every outcome.
- HighCare plan
Management is individualized and may involve several specialists according to symptoms.
- MediumWhat is uncertain
These sources do not establish exact risks, laboratory cutoffs, treatments, or life expectancy.